In this pilot study, we demonstrated that rivastigmine was well tolerated in patients with CIND because of cerebrovascular disease and may potentially improve executive functioning.
Authors: Kaavya Narasimhalu, Sahara Effendy, Christopher Sim, J. M. Lee, I‐Ju Chen, S. B. Hia, Huiping Xue, Marilyn Corrales, Hsin-Te Chang, M. C. Wong, Christopher Chen, Eng‐King Tan
DOI: https://doi.org/10.1111/j.1600-0404.2009.01263.x
Publish Year: 2009
